Intensive Care Anxiety in SARS-CoV-2 Patients

• Conditions: Anxiety
• Interventions: Behavioral: Hospital Anxiety Depression Measure

• Registration Number: NCT04715477
• Lead Sponsor: Derince Training and Research Hospital

Brief Summary

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-01
• Study First Submitted: 2021-01-15
• Study First Submitted QC: 2021-01-16
• Last Update Submitted: 2021-01-16
• Study Start: 2021-01-17
• Study First Posted: 2021-01-20
• Last Update Posted: 2021-01-20
• Primary Completion: 2021-04-01
• Study Completion: 2021-04-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Above 18 years old
• COVID PCR +,
• admitted to intensive care,
• conscious, cooperative patients

Exclusion Criteria

• Having hearing and speaking problems,
• Can't speak Turkish or English,
• who do not have the cognitive level to understand and answer the questions,
• Communication problems such as dementia and Alzheimer's,
• patients receiving sedation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Hospital Anxiety Depression Measure	Hospital Anxiety Depression Measure	Hospital Anxiety Depression Measure

Primary Outcome Measures

Name	Time	Method
intensive care Anxiety	3 month	Hospital Anxiety Depression scale

Trial Locations

Locations (1)

İlke Küpeli; 🇹🇷 İ̇zmi̇t, Kocaeli̇, Turkey